Exact Mass: 539.322

Exact Mass Matches: 539.322

Found 43 metabolites which its exact mass value is equals to given mass value 539.322, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

1-(3-((((2R,3S,4R,5R)-5-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea

1-(3-((((2R,3S,4R,5R)-5-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea

C28H41N7O4 (539.322)


   

Cholylmethionine

2-[(1-Hydroxy-4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}pentylidene)amino]-4-(methylsulphanyl)butanoic acid

C29H49NO6S (539.328)


Cholylmethionine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholylmethionine consists of the bile acid cholic acid conjugated to the amino acid Methionine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholylmethionine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholylmethionine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

1-Nonadecanoyl-glycero-3-phosphoserine

2-amino-3-{[hydroxy(2-hydroxy-3-(nonadecanoyloxy)propoxy)phosphoryl]oxy}propanoic acid

C25H50NO9P (539.3223)


   
   

His Lys Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-carbamoylbutanamido]hexanoic acid

C23H41N9O6 (539.318)


   

Lys Gln His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C23H41N9O6 (539.318)


   

Methiocholic acid putative

Methiocholic acid putative

C29H49NO6S (539.328)


   
   

Methionine conjugated cholic acid

Methionine conjugated cholic acid

C29H49NO6S (539.328)


   

His Lys Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]hexanamido]-4-carbamoylbutanoic acid

C23H41N9O6 (539.318)


   

His Gln Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]hexanamido]hexanoic acid

C23H41N9O6 (539.318)


   

Lys His Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-carbamoylbutanoic acid

C23H41N9O6 (539.318)


   

Lys His Gln Lys

(2S)-6-amino-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]butanamido]hexanoic acid

C23H41N9O6 (539.318)


   

Lys Lys His Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C23H41N9O6 (539.318)


   

Lys Lys Gln His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N9O6 (539.318)


   

Lys Gln Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N9O6 (539.318)


   

Gln His Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]hexanoic acid

C23H41N9O6 (539.318)


   

Gln Lys His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C23H41N9O6 (539.318)


   

Gln Lys Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N9O6 (539.318)


   

PS(19:0/0:0)

1-nonadecanoyl-glycero-3-phosphoserine

C25H50NO9P (539.3223)


   

LPS 19:0

1-nonadecanoyl-glycero-3-phosphoserine

C25H50NO9P (539.3223)


   

LPS O-19:1;O

1-(2-methoxy-6Z-octadecenyl)-sn-glycero-3-phosphoserine

C25H50NO9P (539.3223)


   
   

3,3,20,20-Bis(ethylene-dioxy)-5α,17α-dihydroxy-11β-4-(N,N-diMethylaMino)-phenyl-19-norpregna-9(11)-ene

3,3,20,20-Bis(ethylene-dioxy)-5α,17α-dihydroxy-11β-4-(N,N-diMethylaMino)-phenyl-19-norpregna-9(11)-ene

C32H45NO6 (539.3247)


   

1-OCTADECYL-4-(4-PHENYL-1,3-BUTADIENYL)PYRIDINIUM BROMIDE

1-OCTADECYL-4-(4-PHENYL-1,3-BUTADIENYL)PYRIDINIUM BROMIDE

C33H50BrN (539.3126)


   

Adamantane-1-carboxylic acid-5-dimethylamino-naphthalene-1-sulfonylamino-octyl-amide

Adamantane-1-carboxylic acid-5-dimethylamino-naphthalene-1-sulfonylamino-octyl-amide

C31H45N3O3S (539.3181)


   

(2S)-2-amino-3-[hydroxy-[(2R)-1,1,2,3,3-pentadeuterio-2-hydroxy-3-nonadecanoyloxypropoxy]phosphoryl]oxypropanoic acid

(2S)-2-amino-3-[hydroxy-[(2R)-1,1,2,3,3-pentadeuterio-2-hydroxy-3-nonadecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C25H50NO9P (539.3223)


   

1-nonadecanoyl-glycero-3-phosphoserine

1-nonadecanoyl-glycero-3-phosphoserine

C25H50NO9P (539.3223)


   

PS(19:0)

PS(10:0(1)_9:0)

C25H50NO9P (539.3223)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

PE O-16:0/4:1;O2

PE O-16:0/4:1;O2

C25H50NO9P (539.3223)


   
   
   
   
   
   
   

ST 24:5;O;HexNAc

ST 24:5;O;HexNAc

C32H45NO6 (539.3247)


   

ST 27:2;O3;Tau

ST 27:2;O3;Tau

C29H49NO6S (539.328)


   

(3s,6r,9s,12s,19s)-19-butyl-5,8,11,14,17-pentahydroxy-12-isopropyl-3,6-dimethyl-9-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one

(3s,6r,9s,12s,19s)-19-butyl-5,8,11,14,17-pentahydroxy-12-isopropyl-3,6-dimethyl-9-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one

C26H45N5O7 (539.3319)


   

(3s,6s,9r,12s,19s)-19-[(2s)-butan-2-yl]-5,8,11,14,17-pentahydroxy-12-isopropyl-3,6-dimethyl-9-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one

(3s,6s,9r,12s,19s)-19-[(2s)-butan-2-yl]-5,8,11,14,17-pentahydroxy-12-isopropyl-3,6-dimethyl-9-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one

C26H45N5O7 (539.3319)


   

19-butyl-5,8,11,14,17-pentahydroxy-12-isopropyl-3,6-dimethyl-9-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one

19-butyl-5,8,11,14,17-pentahydroxy-12-isopropyl-3,6-dimethyl-9-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one

C26H45N5O7 (539.3319)


   

5,8,11,14,17-pentahydroxy-12-isopropyl-3,6-dimethyl-9-(2-methylpropyl)-19-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one

5,8,11,14,17-pentahydroxy-12-isopropyl-3,6-dimethyl-9-(2-methylpropyl)-19-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one

C26H45N5O7 (539.3319)